Harpoon Therapeutics, Inc. Profile Avatar - Palmy Investing

Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United…

Biotechnology
US, South San Francisco [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of HARP's Analysis
CIK: 1708493 CUSIP: 41358P106 ISIN: US41358P2056 LEI: - UEI: -
Secondary Listings
HARP has no secondary listings inside our databases.